-
4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners
04 Apr 2025 20:48 GMT
… drug for the treatment of multiple myeloma
Opdivo for anti-cancer indications
Eliquis … corporation specializing in pharmaceuticals, biotechnology, and medical devices. With a …
The company offers medicines and vaccines in various therapeutic areas …
-
Luján warns tariffs will increase prescription drug costs
03 Apr 2025 23:55 GMT
… impacts of prescription drug increases on consumers and domestic pharmaceutical manufacturers.
“We … States. They cited the anticoagulant drug Eliquis, which has its API … of this already costly drug, further increasing Medicare spending and burdening …
-
API-CAT Trial Shows Reduced-Dose Eliquis Matches Full Dose in Preventing Venous Thromboembolism, Lowers Bleeding Risk in Cancer Patients
03 Apr 2025 00:09 GMT
… Medicine, also show Eliquis significantly lowered the risk of clinically relevant bleeding.
“Treatment … requires consideration. In the present trial, the incidence of recurrent … to limited data from randomized trials, appropriate and effective regimens of …
-
Root out Drug Company Abuses to Lower Rx Prices
02 Apr 2025 00:36 GMT
… medications for diseases and chronic conditions, including cancer treatments, … top 10 drugs in advertising spending: Eliquis (blood thinner … the Food and Drug Administration (FDA) with the intent … for pharmaceutical companies to make the investments in drugs …
-
BMY: A High-Yielding Drug Stock With Great Growth Potential
01 Apr 2025 06:55 GMT
… 9% to $3.7 billion. Eliquis, a top-selling anticoagulant, saw … of the pharmaceutical industry, as demand for its lifesaving drugs remains steady … its robust pipeline, high-margin pharmaceutical products, and strategic acquisitions, such …
-
Reduced-Dose Eliquis Gets the Nod in Study of Cancer Patients| ACC 2025
29 Mar 2025 16:43 GMT
… Cité and head of internal medicine at Public Assistance Hospitals … For the purposes of this trial, a reduced dose was … primary efficacy endpoint of the trial.
The results for a … treatment with a reduced dose of Eliquis was “noninferior” to full-dose treatment …
-
Big Pharma's $13.8B DTC ad spend drives drug costs
20 Mar 2025 11:48 GMT
… rising drug costs
Since the FDA loosened regulations in 1997, pharmaceutical advertising … heavily marketed drugs have also seen significant price hikes. Eliquis (Bristol … for pharmaceutical companies. If tax deductions were eliminated, drugmakers might …
-
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
20 Mar 2025 12:35 GMT
… Gaslightwala is a biotechnology and pharmaceutical industry veteran bringing … ®, XGEVA®, Repatha®, and ELIQUIS®. His experience spans business … antibody drug conjugates (ADC) for the treatment of … candidates to clinical trials, therapeutic applications, …
-
IRA round 2 begins as drugmakers sign on to price negotiation process with CMS
18 Mar 2025 23:14 GMT
… of the drugmakers that make the fifteen medicines selected for 2027 … 53% price reduction to its Eliquis “does not reflect the … Industry trade group the Pharmaceutical Research and Manufacturers of America … to fix IRA’s “pill penalty” and reverse the …
-
Factbox-Widely used drugs on US imports list from Europe
18 Mar 2025 17:08 GMT
… - Widely used prescription medicines could get caught up in … Nord also used bulk vaccine/;bulk drug ic for mpox … Ireland,
Story Continues ty vaccine Germany Eliquis blood Netherlan (apixa thinner… colorectal comment on which drug is zumab) cancer, produced …